Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 16037742 | Applicator For Applying A Fluid To A Surface | A61M, A61K | Jul 16, 2018 | Jan 1, 2021 |
| 15835801 | Stable Pharmaceutical Composition Of Phytonadione And A Novel Process For Preparation Thereof | A61K | Dec 7, 2017 | Jan 20, 2020 |
| 16071263 | Polymorphic Forms Of Vortioxetine Hydrobromide Tert-Butanolate | C07D | Jan 18, 2017 | Mar 2, 2020 |
| 16066425 | Crystalline Form Of Ticagrelor | C07D | Jan 2, 2017 | Apr 11, 2019 |
| 15774854 | Process for the Preparation of Eltrombopag Olamine | C07D, C07C | Nov 7, 2016 | Jun 9, 2019 |
| 15752082 | Process For Preparation Of Vortioxetine Hydrobromide | C07C | Aug 17, 2016 | Sep 26, 2019 |
| 15200168 | Stable Pharmaceutical Composition Of Amorphous Ticagrelor | A61K | Jun 30, 2016 | Mar 26, 2019 |
| 15577919 | Process for the Preparation of Darunavir | C07C, C07D | Jun 2, 2016 | Sep 11, 2019 |
| 15548616 | PROCESS FOR GRANULATING SEVELAMER CARBONATE | A61K | Feb 18, 2016 | Apr 29, 2019 |
| 14058609 | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof | A61K | Oct 20, 2013 | Oct 13, 2015 |
| 13051212 | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof | B05D, A61K, A61P | Mar 17, 2011 | Nov 17, 2013 |
| 13519093 | Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer | A61J, A61K | Dec 27, 2010 | Jan 9, 2016 |
| 12649943 | PHARMACEUTICAL DOSAGE FORMS AND METHODS OF MANUFACTURING SAME | A61K, A61P, B05D | Dec 29, 2009 | May 3, 2015 |
| 12192609 | MULTIPARTICULATE SELECTIVE SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR FORMULATION | A61K | Aug 14, 2008 | Dec 17, 2011 |
| 12167876 | ENTERIC COATED HYDROPHOBIC MATRIX FORMULATION | A61K | Jul 2, 2008 | Dec 1, 2010 |
| 12037124 | Controlled Release Muscarinic Receptor Antagonist Formulation | A61P, A61K | Feb 25, 2008 | Aug 12, 2014 |
| 11138008 | Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist | A61K | May 25, 2005 | Nov 4, 2009 |
| 11025013 | Oral disintegrating dosage forms | A61K, B27N | Dec 29, 2004 | Jan 12, 2009 |
| 10815929 | Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist | A61K | Apr 1, 2004 | Apr 29, 2007 |
| 10815930 | Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist | A61K | Apr 1, 2004 | Apr 29, 2007 |